Abstract
Purpose
Neurogenic bladder is a common complication of several central nervous system injuries. Statins and phosphodiesterase-5 (PDE-5) inhibitors are reportedly beneficial in neural injuries and urinary system dysfunction. The effect of simvastatin, sildenafil and tadalafil on several renal function indices of an animal model of neurogenic bladder was investigated.
Methods
Forty male rats were assessed in five equal groups. Dura mater and the cord were injured with an aneurysmal clamp at the level of T9–T10 in all rats except in sham group. The sham and control groups (treated by normal saline), simvastatin (4 mg/kg), sildenafil (5 mg/kg), and tadalafil (2 mg/kg) groups received treatment (i.p.) for seven consecutive days following injury. Renal system and motor functions were assessed at day 28 following injury. Data were analyzed by analysis of variance followed by the Student–Newman–Keuls post hoc test.
Results
Simvastatin improved both the renal and the motor function compared with the control group. However, sildenafil and tadalafil could only improve the motor function but could not make any significant differences in renal indices in comparison with the control group.
Conclusion
Statins can effectively improve the motor and renal functions in a condition of renal dysfunction in a rat model of neurogenic bladder. PDE-5 inhibitors could help to improve motor function, but are not helpful in renal function, at least in short time.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Ku JH (2006) The management of neurogenic bladder and quality of life in spinal cord injury. BJU Int 98:739–745
Bauer SB (2008) Neurogenic bladder: etiology and assessment. Pediatr Nephrol 23:541–551
Wu HY, Baskin LS, Kogan BA (1997) Neurogenic bladder dysfunction due to myelomeningocele: neonatal versus childhood treatment. J Urol 157:2295–2297
Panicker JN, de Sèze M, Fowler CJ (2010) Rehabilitation in practice: neurogenic lower urinary tract dysfunction and its management. Clin Rehabil 24:579–589
Scales CD Jr, Wiener JS (2008) Evaluating outcomes of enterocystoplasty in patients with spina bifida: a review of the literature. J Urol 180:2323–2329
Pahan K, Sheikh FG, Namboodiri AM, Singh I (1997) Lovastatin and phenylacetate inhibit the induction of nitric oxide synthase and cytokines in rat primary astrocytes, microglia, and macrophages. J Clin Invest 100(11):2671–2679
Paintlia AS, Paintlia MK, Singh I, Singh AK (2008) Combined medication of lovastatin with rolipram suppresses severity of experimental autoimmune encephalomyelitis. Exp Neurol 214(2):168–180
Lin CL, Cheng H, Tung CW, Huang WJ, Chang PJ, Yang JT, Wang JY (2008) Simvastatin reverses high glucose-induced apoptosis of mesangial cells via modulation of Wnt signaling pathway. Am J Nephrol 28:290–297
Tsujihata M, Momohara C, Yoshioka I, Tsujimura A, Nonomura N, Okuyama A (2008) Atorvastatin inhibits renal crystal retention in a rat stone forming model. J Urol 180:2212–2217
Shunmugavel A, Khan M, Te Chou PC, Dhindsa RK, Martin MM, Copay AG, Subach BR, Schuler TC, Bilgen M, Orak JK, Singh I (2010) Simvastatin protects bladder and renal functions following spinal cord injury in rats. J Inflamm (Lond) 7:17
Roehrborn CG, McVary KT, Elion-Mboussa A, Viktrup L (2008) Tadalafil administered once daily for lower urinary tract symptoms secondary to benign prostatic hyperplasia: a dose finding study. J Urol 180:1228–1234
Oger S, Behr-Roussel D, Gorny D, Lebret T, Validire P, Cathelineau X, Alexandre L, Giuliano F (2010) Signalling pathways involved in sildenafil-induced relaxation of human bladder dome smooth muscle. Br J Pharmacol 160(5):1135–1143
Caremel R, Oger-Roussel S, Behr-Roussel D, Grise P, Giuliano FA (2010) Nitric oxide/cyclic guanosine monophosphate signalling mediates an inhibitory action on sensory pathways of the micturition reflex in the rat. Eur Urol 58:616–625
Thomas C, Kim JH, Torimoto K, Kwon DD, Kim YT, Tyagi P, Yoshimura N, Chancellor MB (2007) Early capsaicin intervention for neurogenic bladder in a rat model of spinal cord injury. Biomed Res 28(5):255–259
De Groat WC, Yoshimura N (2010) Changes in afferent activity after spinal cord injury. Neurourol Urodyn 29:63–76
Basso DM, Beattie MS, Bresnahan JC (1996) Graded histological and locomotor outcomes after spinal cord contusion using the NYU weight-drop device versus transection. Exp Neurol 139:244–256
Kim D, Sands JM, Klein JD (2003) Changes in renal medullary transport proteins during uncontrolled diabetes mellitus in rats. Am J Physiol Renal Physiol 285(2):F303–F309
Mimata H, Satoh F, Tanigawa T, Nomura Y, Ogata J (1993) Changes of rat urinary bladder during acute phase of spinal cord injury. Urol Int 51:89–93
Serarslan Y, Yönden Z, Ozgiray E, Oktar S, Güven EO, Söğüt S, Yilmaz N, Yurtseven T (2010) Protective effects of tadalafil on experimental spinal cord injury in rats. J Clin Neurosci 17(3):349–352
Agarwal R (2006) Effects of statins on renal function. Am J Cardiol 97(5):748–755
Choi K, Kang SW, Lee SW, Lee HY, Han DS, Kang BS (1995) The effect of lovastatin on proliferation of cultured rat mesangial and aortic smooth muscle cells. Yonsei Med J 36:251–261
Khan SR (2005) Hyperoxaluria-induced oxidative stress and antioxidants for renal protection. Urol Res 33:349–357
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Mirzaii-Dizgah, I., Salmanyan, B. Renal function in a rat model of neurogenic bladder, effect of statins and phosphodiesterase-5 inhibitors. Eur Spine J 22, 2766–2769 (2013). https://doi.org/10.1007/s00586-013-2927-x
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00586-013-2927-x